Clinical Trials Browser

NIH × Glioblastoma × cemiplimab × Clear all

NCT07422363 2026-06-12

Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma

Phase 1 Not yet recruiting

Glioblastoma, Gliosarcoma